Facebook Share

Saturday, April 05, 2014

Supercharge Your Sperm: 5 Ways

1: Never smoke--smoking is very harmful to sperm function
2: Do not take exogenous T: testosterone given via injection or as a topical gel eliminates sperm production
3: Stay thin: abdominal fat (the rubber tire) alters the reproductive hormonal balance
4: Exercise: helps overall health in general and sexual functioning in specific
5: Eat healthy: diets rich in anti-oxidants, such as green leafy vegetables, can diminish levels of reactive oxidative species present in genital fluid (I don't recommend any herbal supplements--save your money)

Good luck

Dr Schoor

Tuesday, April 01, 2014

Now Offering AVEED

I now offer the newest form of TRT, AVEED.  This is a 10 week lasting TRT injection.  Please read below prior to deciding if you wish to proceed with this form of testosterone replacement therapy.

Explain to patients:

  • The importance of providing an accurate medical history about any previous allergic reactions to AVEED or its components (testosterone undecanoate, castor oil and benzyl benzoate)
  • AVEED can only be administered by a trained Healthcare Provider in a certified healthcare setting
  • The risks of serious POME reactions and anaphylaxis associated with AVEED
  • POME is not a blood clot
  • How to recognize the symptoms of serious POME reactions and anaphylaxis
  • Report signs and symptoms to the healthcare setting staff immediately. These include:
- swelling of your face, tongue, or throat
- hoarseness or trouble speaking 
- difficulty breathing 
- feeling flushed 
- itching or rash including hives
- coughing or urge to cough 
- tightening in your throat 
- numbness and tingling in your arms 
- dizziness 
- feeling very sweaty
- chest pain 
- feeling unwell
- fainting 
- pain in your stomach 
- vomiting or throwing up

Friday, March 07, 2014

AUA Statement onTRT


The American Urological Association (AUA) has followed closely the recent media attention regarding reports that testosterone therapy increases cardiovascular events in men as well as the FDA's stated intent to review cardiovascular risk with this treatment in men with hypogonadism. The AUA notes there is also contradictory evidence suggesting a beneficial influence of testosterone therapy on cardiovascular risk. Definitive studies have not been performed.
The AUA is also concerned about the potential for misuse of testosterone for non-medical indications, such as body building or performance enhancement.
Hypogonadism is defined as biochemically low testosterone levels in the setting of a cluster of symptoms which may include reduced sexual desire (libido) and activity, decreased spontaneous erections, decreased energy and depressed mood. Men with hypogonadism may also experience reduced muscle mass and strength and increased body fat. Hypogonadism may also contribute to reduced bone mineral density and anemia. Testosterone therapy is an appropriate treatment for hypogonadism after full discussion of potential adverse effects. Treatment requires follow-up and medical monitoring. Testosterone therapy in the absence of hypogonadism is not appropriate.
Increased awareness about hypogonadism has been stimulated by an increase in availability and diversity of patient-acceptable forms of testosterone replacement options in recent years. The management of hypogonadism should start with careful evaluation by a physician experienced in diagnosing hypogonadism. Many of the symptoms are non-specific and may be multifactorial in origin. Hence, symptoms may not be necessarily linked to hypogonadism alone. This fact needs to be considered in the overall evaluation.
The diagnosis and management of testosterone deficiency should be made by a physician with training in the condition and its treatments. The diagnosis should be made only after taking detailed medical history, physical examination, and obtaining appropriate blood tests. Testosterone therapy should not be offered to men with normal testosterone levels. Testosterone therapy is never a treatment for infertility.
The potential adverse effects of testosterone therapy should be discussed prior to treatment. These include acne, breast swelling or tenderness, increased red blood cell count, swelling of the feet or ankles, reduced testicular size and infertility. Current evidence does not provide any definitive answers regarding the risks of testosterone therapy on prostate cancer and cardiovascular disease, and patients should be so informed.
The optimal follow-up of men on testosterone therapy has not been defined, but should include measurement of testosterone level, PSA and hematocrit. Other patient-specific measures may be appropriate.
The AUA recognizes and encourages the need for increased educational awareness of the benefits and risks of testosterone therapy among both patients and health care providers.
Board of Directors, February 2014

Thursday, March 06, 2014

And the prostate cancer treatment debate continues.

Surgery Linked To Better Survival In Patients With Early Prostate Cancer.

The Wall Street Journal (3/6, A2, Whalen, Subscription Publication) reports that research published in the New England Journal of Medicine suggests that for patients with early-stage prostate cancer, surgery to remove the prostate may be linked to better survival than watchful waiting.

        The Los Angeles Times (3/6, Kaplan) “Science Now” blog reports that the nearly 700 “men in the Scandinavian Prostate Cancer Group Study Number 4 all hailed from Sweden, Finland or Iceland, and all had localized tumors.”

        The AP (3/6, Marchione) reports that “half were given surgery to remove their prostates and the rest were closely monitored and given surgery only if symptoms or signs of cancer worsened.”

        On its website, CNN (3/6, Hellerman) reports, “On average,” participants “who underwent immediate surgery lived longer, were less likely to see the cancer spread and had fewer complications from the disease.” The data indicated that “the longevity benefit was greatest for men in their 50s and early 60s, where over an 18-year period, surgery cut the death rate by more than a third.”

        The Boston Globe (3/6, Kotz) points out that these findings seem “to contradict what other researchers found in a 2012 trial of US patients: men with early-stage prostate cancer, regardless of their age, received no life- extending benefit from immediate surgery instead of monitori

Wednesday, March 05, 2014

Actual Patient Testimonials For Dr Schoor

"The entire experience could not have been easier or more pleasant.  I called Dr Schoor's office, came to see him a few days later, had the procedure and drove home.  The procedure was painless, the healing was easy, and 6 weeks later my fertility was restored.  Could not have been easier."
 My husband immediately felt comfortable with Dr. Schoor and his professional and warm bedside manner.  He was thorough and never more than a phone call or email away.  We are currently pregnant and so excited. We could not have done this without the expert hands of Dr. Schoor.  We had a great experience and highly recommend Dr.Schoor !
"Very easy {scheduling] and accommodating"
"beyond professional-courteous, caring and very involved in the outcome"
"placed me at ease throughout the process."
"very pleased [with the outcome].  Will recommend the office to anyone.  Will make the office my urologist as well."